The global market for prostate cancer diagnosis & treatment is projected to have a CAGR of around 9.5% during the forecast period. Various pivotal factors drive the global market such as the rising incidence and prevalence rate of prostate cancer, and growing investment/grants from government and private players across the globe. According to the American Cancer Society, prostate cancer is one of the most common types of cancer in men. About 1 in 9 men are likely to be diagnosed with prostate cancer during their lifetime. The American Cancer Society estimated that around 174,650 new cases and nearly 31,620 mortalities occurred in 2019 in the US. Moreover, the increasing adoption of innovative technologies for the diagnosis of prostate cancer is expected to fuel market growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumors and confirm whether there is a need for tissue biopsy.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/prostate-cancer-diagnosis-treatment-market

The global prostate cancer diagnosis and treatment market hardly hit by the COVID-19 outbreak. The patients affected with prostate cancer are more prone to get affected with Coronavirus, so during the lockdown, they were advised to stay home and avoid all non-emergent diagnoses and treatment. Also, at the time of the COVID-19 pandemic, there was a decrease in cancer diagnosis has been witnessed. Besides, due to a halt in cancer diagnosis and treatments, the market has registered negative growth. Major economies especially the US has suffered a lot during the pandemic as the region has higher patients base affected with various cancers, due to lockdown there was less visit in hospitals for treatments, and the region get negatively impacted. Post COVID-19 it is expected that the market will grow with the “W” shape recovery method, by the increase in demands for cancer treatments & drugs.

A Full Report of Global Prostate Cancer Diagnosis & Treatment Market is Available at: https://www.omrglobal.com/industry-reports/prostate-cancer-diagnosis-treatment-market

Geographically, the global prostate cancer diagnosis & treatment market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). Among these, Asia-Pacific is estimated to be the fastest growing region during the forecast period. The high prevalence of prostate cancer in the region coupled with the rapidly evolving healthcare infrastructure in major economies such as China and India are fueling the growth of the prostate cancer diagnosis & treatment market. Besides, the growing awareness about prostate cancer diagnosis and treatments, developing R&D sector, and technological advancements in healthcare further drives the market growth in the region.

Global Prostate Cancer Diagnosis & Treatment Market– Segmentation
By Diagnostic Techniques
Prostate Specific Antigen Test (PSA)
Digital Rectal Exam (DRE)
By Therapy
Hormonal Therapy
Chemotherapy
Immunotherapy
Radiation Therapy
Targeted Therapy

Global Prostate Cancer Diagnosis & Treatment Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
Abbott Laboratories
AbbVie Inc.
Active Biotech AB.
Amgen Inc.
Astellas Pharma Inc
AstraZeneca PLC
Bavarian NordicA/S
Bayer AG
Bristol-Myers Squibb Co.
Dendreon Pharmaceuticals LLC
Endo International plc
Ferring B.V.
GE Healthcare
GlaxoSmithKline plc
Ipsen Pharma
Johnson & Johnson Services, Inc
Pfizer Inc.
Sanofi S.A.
Siemens AG
Takeda Pharmaceutical Co. Ltd.
Teva Pharmaceutical Industries Ltd.
Tolmar Pharmaceuticals, Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/prostate-cancer-diagnosis-treatment-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404